We focused on two signaling pathways activated in cancer, Akt and Erk pathways, because a previous report showed that Akt and Erk pathways are correlated with cell proliferation as a downstream pathway of Eph/ephrin interactions [15]. The gene discussed is AKT1; the disease is cancer.